Vessel plus最新文献_第10页

Vascular and metabolic risk factors of late-life depression 晚年抑郁症的血管和代谢危险因素

Vessel plus Pub Date : 2022-01-01 DOI: 10.20517/2574-1209.2021.102

Anouk F. J. Geraets, S. Köhler, M. Schram

{"title":"Vascular and metabolic risk factors of late-life depression","authors":"Anouk F. J. Geraets, S. Köhler, M. Schram","doi":"10.20517/2574-1209.2021.102","DOIUrl":"https://doi.org/10.20517/2574-1209.2021.102","url":null,"abstract":"Late-life depression (LLD) is a common complex mood disorder with high comorbidity of both psychiatric and physical diseases, cognitive decline, and increased mortality. The mechanisms underlying LLD are incompletely understood. The heterogeneity of depression complicates research into the underlying mechanisms, and factors involved in LLD may differ from those involved in early-life depression. This narrative review provides an overview of (micro-)vascular and metabolic factors involved in the development of LLD. Evidence suggests that cerebral small vessel disease, generalized microvascular dysfunction, and metabolic risk factors, including diabetes and inflammation, may contribute to the development of LLD, while the role of neurodegeneration needs further in-depth investigation. Accordingly, vascular and metabolic factors may provide promising targets for the prevention and improvement of treatment of LLD. Guidelines to screen for LLD in cardiovascular care need further implementation, as do integrated care approaches that treat LLD and diabetes jointly. However, intervention studies are needed to assess which interventions are appropriate and most effective in clinical practice.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67654177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

Diagnosis of cardiac murmurs in children 儿童心脏杂音的诊断

Vessel plus Pub Date : 2022-01-01 DOI: 10.20517/2574-1209.2021.105

P. Rao

引用次数: 1

Management of chronic type B aortic dissection 慢性B型主动脉夹层的处理

Vessel plus Pub Date : 2022-01-01 DOI: 10.20517/2574-1209.2021.125

J. Trahanas, O. Jarral, Chandler Long, G. Hughes, Frank W. Sellke

引用次数: 1

Disclosing the cardiomyopathic substrate within the heart muscles in amyloidosis by cardiac magnetic resonance: diagnostic and prognostic implications 通过心脏磁共振揭示淀粉样变性患者心肌内的心肌病底物:诊断和预后意义

Vessel plus Pub Date : 2022-01-01 DOI: 10.20517/2574-1209.2021.81

S. Pica, M. Lombardi

引用次数: 0

Daily atrial fibrillation issues: the view-point of a practicing surgeon 日常房颤问题:一个执业外科医生的观点

Vessel plus Pub Date : 2022-01-01 DOI: 10.20517/2574-1209.2021.118

T. Bilfinger

引用次数: 0

Reduced myocardial perfusion is common among subjects with ischemia and no obstructive coronary artery disease and heart failure with preserved ejection fraction: a report from the WISE-CVD continuation study. 心肌灌注减少在心肌缺血、无阻塞性冠状动脉疾病和射血分数保留型心力衰竭患者中很常见：WISE-CVD 持续研究报告。

Vessel plus Pub Date : 2022-01-01 Epub Date: 2022-03-05 DOI: 10.20517/2574-1209.2021.103

Haider Aldiwani, Michael D Nelson, Behzad Sharif, Janet Wei, T Jake Samuel, Nissi Suppogu, Odayme Quesada, Galen Cook-Wiens, Edward Gill, Lidia S Szczepaniak, Louise E J Thomson, Balaji Tamarappoo, Anum Asif, Chrisandra Shufelt, Daniel Berman, C Noel Bairey Merz

{"title":"Reduced myocardial perfusion is common among subjects with ischemia and no obstructive coronary artery disease and heart failure with preserved ejection fraction: a report from the WISE-CVD continuation study.","authors":"Haider Aldiwani, Michael D Nelson, Behzad Sharif, Janet Wei, T Jake Samuel, Nissi Suppogu, Odayme Quesada, Galen Cook-Wiens, Edward Gill, Lidia S Szczepaniak, Louise E J Thomson, Balaji Tamarappoo, Anum Asif, Chrisandra Shufelt, Daniel Berman, C Noel Bairey Merz","doi":"10.20517/2574-1209.2021.103","DOIUrl":"10.20517/2574-1209.2021.103","url":null,"abstract":"Aim: Women with evidence of ischemia and no obstructive coronary artery disease (INOCA) have an increased risk of major adverse cardiac events, including heart failure with preserved ejection fraction (HFpEF). To investigate potential links between INOCA and HFpEF, we examined pathophysiological findings present in both INOCA and HFpEF.Methods: We performed adenosine stress cardiac magnetic resonance imaging (CMRI) in 56 participants, including 35 women with suspected INOCA, 13 women with HFpEF, and 8 reference control women. Myocardial perfusion imaging was performed at rest and with vasodilator stress with intravenous adenosine. Myocardial perfusion reserve index was quantified as the ratio of the upslope of increase in myocardial contrast at stress vs. rest. All CMRI measures were quantified using CVI42 software (Circle Cardiovascular Imaging Inc). Statistical analysis was performed using linear regression models, Fisher's exact tests, ANOVA, or Kruskal-Wallis tests.Results: Age (P = 0.007), Body surface area (0.05) were higher in the HFpEF group. Left ventricular ejection fraction (P = 0.02) was lower among the INOCA and HFpEF groups than reference controls after age adjustment. In addition, there was a graded reduction in myocardial perfusion reserve index in HFpEF vs. INOCA vs. reference controls (1.5 ± 0.3, 1.8 ± 0.3, 1.9 ± 0.3, P = 0.02), which was attenuated with age-adjustment.Conclusion: Reduced myocardial perfusion reserve appears to be a common pathophysiologic feature in INOCA and HFpEF patients.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"6 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9278056/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10785179","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Improving future postoperative atrial fibrillation care: a 30,000-foot viewpoint 改善未来的术后房颤护理:3万英尺的观点

Vessel plus Pub Date : 2022-01-01 DOI: 10.20517/2574-1209.2021.120

Daniel F Pardo, F. Grover, Jessica Y. Rove, A. Shroyer

{"title":"Improving future postoperative atrial fibrillation care: a 30,000-foot viewpoint","authors":"Daniel F Pardo, F. Grover, Jessica Y. Rove, A. Shroyer","doi":"10.20517/2574-1209.2021.120","DOIUrl":"https://doi.org/10.20517/2574-1209.2021.120","url":null,"abstract":"Aim: In the United States (US), post-operative atrial fibrillation (POAF) is the most common complication following cardiac surgery. In order to understand the opportunities to improve POAF patients’ care, this “30,000 foot” review evaluated the professional society POAF database/registry definitions and guideline recommendations. Methods: All US-based professional society organizations with an interventional cardiac database/registry and/or cardiac care guidelines were identified; from these, the POAF database definitions and guideline recommendations were evaluated using a content analysis approach. Results: The Society of Thoracic Surgeons (STS) POAF definition was the most frequently referenced definition (21% of key references). Only 50% (n = 5/10) US cardiac surgery databases/registries included any POAF definition; compared to STS, the other five definitions required substantially more detailed documentation. Across eight guidelines, three different types of POAF recommendations were found: risk assessment (n = 3); prevention (n = 7); and management (n = 8). As a common feature, the risk assessment strategies tended to focus on advanced age (n = 6). Beta-blockers (n = 5) and amiodarone (n = 6) were common prevention approaches. Uniformly, anti-coagulation was the only management strategy (n = 8) recommended, barring any contraindications. Conclusion: Across ten professional societies, 50% had no POAF definition; of the remaining five, no POAF definitional consistency was found. Across the eight US-based professional society POAF-related guidelines, only anticoagulation was uniformly recommended. Given these “big picture” findings, professional societies are urged to work collaboratively to harmonize these divergent POAF definitions and consolidate their evidence-based guideline recommendations to improve future POAF patients’ quality of care.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67654843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Global variation in the incidence of new-onset postoperative atrial fibrillation after cardiac and non-cardiac surgery: a systematic review 心脏和非心脏手术后新发房颤发生率的全球变化:系统回顾

Vessel plus Pub Date : 2022-01-01 DOI: 10.20517/2574-1209.2021.146

Daniel F Pardo, A. L. Shroyer, T. Bilfinger

{"title":"Global variation in the incidence of new-onset postoperative atrial fibrillation after cardiac and non-cardiac surgery: a systematic review","authors":"Daniel F Pardo, A. L. Shroyer, T. Bilfinger","doi":"10.20517/2574-1209.2021.146","DOIUrl":"https://doi.org/10.20517/2574-1209.2021.146","url":null,"abstract":"Aim: In the US, postoperative atrial fibrillation (POAF) is the most common complication after cardiac surgery and a frequent complication after non-cardiac surgery, causing excess patient length of stay and costs. After a comprehensive review looking for validated statistically significant data sets, too few data, particularly from outside of the US and Europe, could be found to perform a conclusive analysis, but there is enough data for a well-informed, educated opinion. Methods: A systematic review analyzing 28 international and US studies of POAF hospital length of stay were identified; from this excess and % excess along with total patient length of stay were calculated, where excess patient length of stay is defined as the difference in post-operative stay between POAF and non-POAF patients in days. Geographic variabilities were calculated using chi-square analyses for US regions and international comparisons for a variety of surgical procedures with POAF. Results: Geographic variability analyses when corrected for total hospital stay showed a 325% longer excess patient length of stay (days) in the US vs. Europe (3.4 days vs. 0.8 days) for coronary artery bypass grafting (CABG). It also showed a 27.3% longer excess patient length of stay (days) in the US vs. Europe (4.2 days vs. 3.3 days) for lung resections. These were both statistically significant at P < 0.001. Conclusion: There appear to be substantial variations in POAF-related care practices worldwide. In all practice settings, POAF causes increased patient length of stay. Europeans appear to do better than the US in POAF patients’ length of stay for CABG but not for lung resections. POAF is a worldwide problem where international cooperation in research and development of best practice guidelines would be particularly fruitful.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67655138","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1

Percutaneous catheter-based repeat revascularization in patients with previous PCI or CABG: a comprehensive review of the evidence 既往PCI或CABG患者经皮导管重复血运重建术:证据的综合回顾

Vessel plus Pub Date : 2022-01-01 DOI: 10.20517/2574-1209.2021.85

G. J. Valooran, M. Subbiah, M. Idhrees, Mukesh Karuppannan, M. Bashir, Bashi V. Velayudhan

{"title":"Percutaneous catheter-based repeat revascularization in patients with previous PCI or CABG: a comprehensive review of the evidence","authors":"G. J. Valooran, M. Subbiah, M. Idhrees, Mukesh Karuppannan, M. Bashir, Bashi V. Velayudhan","doi":"10.20517/2574-1209.2021.85","DOIUrl":"https://doi.org/10.20517/2574-1209.2021.85","url":null,"abstract":"Repeat revascularization after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) is one of the most common long-term complications which warrants continuous clinical follow up. Re-interventions negatively impact long-term survival in patients with coronary artery disease. The repeat revascularization after PCI can be either a target lesion revascularization (stent thrombosis/in-stent restenosis) or a revascularization of native coronary artery after PCI (target vessel revascularization/non-target vessel revascularization). The EVENT registry reports that repeat revascularization rates in patients undergoing PCI is 12% in the first year of follow up. Repeat revascularization with additional stent deployment increases the rate of stent thrombosis and restenosis, thereby leading to recurrent ischemic events. Repeat revascularization after CABG can be either in the early postoperative period or later due to native disease progression or late graft stenosis. The need for re-intervention after surgical or percutaneous revascularization is inevitable and is dependent on modifiable and non-modifiable risk factors.","PeriodicalId":75299,"journal":{"name":"Vessel plus","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67655511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Echocardiography: an overview - Part III 超声心动图:概述-第三部分

Vessel plus Pub Date : 2022-01-01 DOI: 10.20517/2574-1209.2021.93

P. Rao

引用次数: 1